TLSI
TriSalus Life Sciences, Inc.
-0.04 (-0.81%)4.89USD30.3K成交股數301M市值–本益比(近四季)6.7股價營收比+1.7%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 11.4M+24% | 8.9M+8% | 11.6M+57% | 11.2M+52% | 9.2M+42% | 8.3M+59% | 7.3M+59% | 7.4M+147% | 6.5M | 5.2M | 4.6M | 3.0M |
| 營業成本 | 1.5M | 1.2M | 1.9M | 1.8M | 1.5M | 1.2M | 1.0M | 912K | 971K | 589K | 772K | 662K |
| 毛利 | 9.9M+29% | 7.7M+9% | 9.7M+52% | 9.4M+46% | 7.7M+40% | 7.0M+53% | 6.3M+65% | 6.5M+178% | 5.5M | 4.6M | 3.8M | 2.3M |
| 毛利率 | 86.8% | 86.2% | 83.5% | 83.9% | 83.7% | 85.3% | 86.3% | 87.6% | 85.0% | 88.7% | 83.3% | 77.8% |
| 研發費用 | 3.1M | 3.2M | 5.2M | 3.7M | 3.0M | 3.0M | 4.2M | 4.7M | 5.8M | 9.5M | 6.9M | 5.6M |
| 銷售管理費用 | 5.2M | 5.5M | 6.7M | 5.9M | 5.2M | 4.7M | 4.7M | 4.0M | 4.6M | 9.0M | 4.9M | 3.6M |
| 營業利益 | −9.8M+34% | −8.4M+11% | −9.0M+3% | −7.3M-10% | −7.3M-37% | −7.6M-59% | −8.7M-24% | −8.2M-19% | −11.7M | −18.6M | −11.4M | −10.1M |
| 營業利益率 | -86.0% | -94.5% | -77.9% | -65.4% | -79.9% | -91.8% | -118.9% | -111.0% | -180.8% | -358.5% | -247.9% | -339.2% |
| 稅後淨利 | −9.2M-11% | 1.5M-115% | −10.8M+351% | −8.3M+91% | −10.4M-21% | −10.1M+609% | −2.4M-83% | −4.3M-48% | −13.2M | −1.4M | −14.0M | −8.3M |
| 淨利率 | -80.5% | 17.3% | -93.5% | -73.9% | -113.2% | -122.4% | -32.6% | -58.8% | -204.5% | -27.4% | -303.2% | -278.6% |
| 稀釋 EPS | -0.16-59% | 0.03-108% | -0.96+700% | -0.27+29% | -0.39-35% | -0.38+171% | -0.12-100% | -0.21-63% | -0.60 | -0.14 | -35.84 | -0.57 |
| 稀釋股數 | 58.3M | 52.3M | 43.1M | 32.9M | 28.5M | 25.3M | 26.5M | 23.9M | 23.3M | 13.2M | 446K | 16.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 46.3M | 56.6M | 22.7M | 26.5M | 13.0M | 8.5M | 11.3M | 16.5M | 4.0M | 21.4M | 104K | 137K |
| 應收帳款 | 6.5M | 5.2M | 5.0M | 5.6M | 5.5M | 5.1M | 4.9M | 4.7M | 4.3M | 3.1M | – | – |
| 存貨 | 4.2M | 3.8M | 3.3M | 3.8M | 4.2M | 4.0M | 4.0M | 3.4M | 2.9M | 1.6M | – | – |
| 總資產 | 62.4M | 71.0M | 36.5M | 41.3M | 28.6M | 24.0M | 27.5M | 32.4M | 17.9M | 33.6M | 12.2M | 20.5M |
| 有息負債 | 33.1M | 33.1M | 32.8M | 32.3M | 31.7M | 22.1M | 21.7M | 21.3M | – | – | – | – |
| 總負債 | 55.9M | 58.2M | 63.2M | 60.7M | 63.0M | 49.9M | 47.9M | 56.6M | 52.8M | 25.1M | 15.3M | 14.2M |
| 股東權益 | 6.6M | 12.8M | −26.7M | −19.4M | −34.4M | −25.9M | −20.4M | −25.3M | −36.0M | 8.3M | −198M | −185M |
| 負債比 | 89.5% | 82.0% | 173.3% | 147.0% | 220.1% | 208.0% | 174.4% | 174.5% | 295.2% | 74.7% | 125.1% | 69.2% |
| 淨現金(現金 − 有息負債) | 13.2M | 23.5M | −10.1M | −5.8M | −18.7M | −13.6M | −10.4M | −4.8M | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −6.5M | – | – | −4.5M-59% | – | – | – | −10.9M | – | – | −10.5M |
| 資本支出 | – | 141K | – | – | 754K | – | – | – | 66K | – | – | 7K |
| 自由現金流 | – | −6.6M | – | – | −5.3M-52% | – | – | – | −10.9M | – | – | −10.5M |
| 折舊攤銷 | – | 135K | – | – | 172K | – | – | – | 175K | – | – | 184K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -74.4% | – | – | -57.3% | – | – | – | -169.3% | – | – | -352.2% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 45.2M | +53.4% | −39.2M | -86.9% | -1.84 | −18.9M |
| FY2024 | 29.4M | +59.0% | −30.0M | -102.1% | -1.31 | −41.2M |
| FY2023 | 18.5M | +49.3% | −59.4M | -320.7% | -6.77 | −51.2M |
| FY2022 | 12.4M | – | −47.2M | -380.6% | -161.55 | −33.0M |
| FY2021 | – | – | 4.8M | –% | – | – |